Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,521.13 103.60 0.72%
TOPIX 1,170.57 3.98 0.34%
HANG SENG 22,760.24 64.23 0.28%

Clovis Oncology to Present at the Morgan Stanley Global Healthcare Conference



  Clovis Oncology to Present at the Morgan Stanley Global Healthcare
  Conference

Morgan Stanley Global Healthcare Conference 2013

Business Wire

BOULDER, Colo. -- September 4, 2013

Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy,
the Company’s President and Chief Executive Officer, will present at the
Morgan Stanley Global Healthcare Conference on Wednesday, September 11, 2013,
at 10:00 AM ET. The conference will be held at the Grand Hyatt New York.

A live webcast of the presentation can be accessed through the investor
relations section of the Company’s website at www.clovisoncology.com.
Following the live presentation, a replay of the webcast will be available on
the Company’s website for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring,
developing and commercializing innovative anti-cancer agents in the U.S.,
Europe and additional international markets. Clovis Oncology targets
development programs at specific subsets of cancer populations, and
simultaneously develops diagnostic tools that direct a compound in development
to the population that is most likely to benefit from its use. Clovis Oncology
is headquartered in Boulder, Colorado, and has additional offices in San
Francisco, California and Cambridge, UK.

Contact:

Clovis Oncology, Inc.
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
or
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement